Chemomab Awarded New European Patent For CM-101, Its First-In Class Monoclonal Antibody In Phase 2 ...
(MENAFN - GlobeNewsWire - Nasdaq) -European Patent Office Grants New Patent Covering Use of CM-101 for the Treatment of Multiple Liver Diseases including Primary Sclerosing Cholangitis- -Further ... ...
Source: wn.com